AG
PLXP

Aperio Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Aperio Group’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,851
Closed -$13K – 2870
2019
Q2 		$13K Buy
+1,851
New +$10K ﹤0.01% 2755

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HWA
Heritage Way Advisors Rockford, Illinois $267M AUM 23.86% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CWM
Cranbrook Wealth Management Bloomfield Hills, Michigan $492M AUM 14.37% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Aperio Group's PLXP Position: Q3 2019 in Review

Aperio Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q3 2019, closing a stake of 1,851 shares — an estimated $13K sold.

Aperio Group first reported a position in PLXP in Q2 2019 and held it in 1 quarter. The position peaked at $13K in Q2 2019. 16 funds tracked by Wall St. Rank hold PLXP as of Q3 2019.

  • Aperio Group reported no remaining PLx Pharma Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Aperio Group sold 1,851 PLx Pharma Inc. Common Stock shares in Q3 2019, an estimated $13K.
  • Aperio Group first reported a position in PLx Pharma Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Aperio Group's PLx Pharma Inc. Common Stock position peaked at $13K in Q2 2019.
  • 16 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.